ФУНДАСИО ПРИВАДА ИНСТИТУТ Д'ИНВЕСТИГАСИО ОНКОЛОХИКА ДЕ ВАЛЬ ХЕБРОН
发明人:
Соусек, Лаура,Болье, Мари-Эв
申请号:
EA202090683
公开号:
EA202090683A3
申请日:
2014.05.07
申请国别(地区):
EA
年份:
2020
代理人:
摘要:
The invention relates to a Myc dominant negative mutant, called Omomyc, for use in medicine and for use in the prevention and/or treatment of cancer. The invention also refers to a fusion protein comprising Omomyc and pharmaceutical composition thereof and their use in medicine and, in particular, for treatment of cancer.